4 results

• Qysmia Diet Drug Hits Market Amid Pregnancy Risks, Other Concerns

  September 19, 2012

  Irvin Jackson

  The new weight loss drug Qsymia was introduced to the market this week, despite the risk of birth defects from...

• Qnexa Diet Pill Approval Delayed in Face of New Safety Plan

  April 11, 2012

  Staff Writers

  Federal drug regulators have decided to delay a decision on whether to approve the weight loss drug Qnexa, which includes...

• Despite Risk of Birth Defects from Topiramate, FDA Panel Approves Diet Drug

  February 23, 2012

  Staff Writers

  An FDA panel of outside advisors has given the nod to a new weight loss drug developed by Vivus, Inc.,...

• Topamax Cleft Palate Problems May Impact New Weight Loss Drug

  January 4, 2012

  Staff Writers

  It appears that concerns about the risk of birth defects from use of Topamax (topiramate) during pregnancy may impact a...